Related Experiment Video
Updated: Jun 15, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
Regulation of fibroblast growth factor-2 by an endogenous antisense RNA and by argonaute-2
Leigh-Ann MacFarlane1, Ying Gu, Alan G Casson
1Department of Physiology and Biophysics, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
Abstract:
We have previously reported that elevated fibroblast growth factor-2 (FGF-2) expression is associated with tumor recurrence and reduced survival after surgical resection of esophageal cancer and that these risks are reduced in tumors coexpressing an endogenous antisense (FGF-AS) RNA. In the present study, we examined the role of the endogenous FGF-AS transcript in the regulation of FGF-2 expression in the human lung adenocarcinoma cell line Seg-1. FGF-2 and FGF-AS were temporally and spatially colocalized in the cytoplasm of individual cells, and knockdown of either FGF-2 or FGF-AS by target-specific siRNAs resulted in dose-dependent up-regulation of the complementary transcript and its encoded protein product. Using a luciferase reporter system, we show that these effects are mediated by interaction of the endogenous antisense RNA with the 3'-untranslated region of the FGF-2 mRNA. Deletion mapping identified a 392-nucleotide sequence in the 5823-nucleotide FGF-2 untranslated tail that is targeted by FGF-AS. Small interfering RNA-mediated knockdown of either FGF-AS or FGF-2 significantly increased the stability of the complementary partner mRNA, demonstrating that these mRNAs are mutually regulatory. Knockdown of FGF-AS also resulted in reduced expression of argonaute-2 (AGO-2) and a number of other elements of the endogenous micro-RNA/RNA interference pathways. Conversely, small interfering RNA-mediated knockdown of AGO-2 significantly increased the stability of the FGF-2 mRNA transcript and the steady-state levels of both FGF-2 mRNA and protein, suggesting a role for AGO-2 in the regulation of FGF-2 expression.
Insights
Fibroblast growth factor-2 (FGF-2) and its antisense RNA (FGF-AS) mutually regulate each other in lung adenocarcinoma cells. FGF-AS targets FGF-2 mRNA, influencing tumor recurrence and survival.
Area of Science:
- Molecular Biology
- Cancer Research
- RNA Biology
Background:
- Elevated fibroblast growth factor-2 (FGF-2) expression correlates with poor outcomes in esophageal cancer.
- Coexpression of endogenous antisense (FGF-AS) RNA with FGF-2 is associated with reduced tumor recurrence and improved survival.
Purpose of the Study:
- To investigate the regulatory role of endogenous FGF-AS in controlling FGF-2 expression within human lung adenocarcinoma cells (Seg-1).
Main Methods:
- Utilized small interfering RNAs (siRNAs) to knock down FGF-2 and FGF-AS expression.
- Employed a luciferase reporter system to analyze mRNA interactions.
- Performed deletion mapping to identify specific RNA binding sites.
- Assessed mRNA stability and protein expression levels.
- Investigated the involvement of argonaute-2 (AGO-2) and micro-RNA pathways.
Main Results:
- FGF-2 and FGF-AS were found to be colocalized in the cytoplasm and mutually regulate each other's expression and stability.
- FGF-AS directly targets the 3'-untranslated region of FGF-2 mRNA.
- Knockdown of FGF-AS led to decreased expression of AGO-2 and other RNA interference pathway components.
- Knockdown of AGO-2 increased FGF-2 mRNA stability and protein levels, suggesting its role in FGF-2 regulation.
Conclusions:
- Endogenous FGF-AS plays a critical role in regulating FGF-2 expression in lung adenocarcinoma through direct interaction with FGF-2 mRNA.
- The FGF-2/FGF-AS axis and the AGO-2 protein are key components in the post-transcriptional regulation of FGF-2, impacting cancer progression.
Related Concept Videos
Experimental RNAi
Regulation of Angiogenesis and Blood Supply
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
TGF - β Signaling Pathway
Regulation of Expression at Multiple Steps
